Filippo Gallina
@filippog92
Followers
352
Following
6K
Media
24
Statuses
637
Thoracic Surgeon at IRCCS National Cancer Institute of Rome. Research Fellow at McGill University, Montréal.
Roma, Lazio
Joined January 2012
RT @LungCancerEu: The VALUE Trial team shows that same-day discharge after VATS lung resection can be done safely for carefully selected pa….
0
9
0
Amazing job of @LyndonCWalsh! Proud to be part of this incredible group. @DoctorJSpicer.
Super proud of our team @MThoracics for putting together this trial showing that same day discharge after lung resection, specifically anatomic lung resection, is both safe and feasible! Would not have been possible without the hard work of @LyndonCWalsh and @MeravRokah, as well.
0
2
3
Break the selective silence on the genocide in Gaza - The Lancet
thelancet.com
Substantial and well-documented evidence indicates a catastrophic public health emergency in Gaza (appendix pp 1–5), marked by severe food insecurity and alarming levels of malnutrition-related...
0
1
2
“Forse facciamo più schifo che spavento”.
💥«Israele è un presidio di legalità», ha detto Matteo Salvini ricevendo il Premio Italia-Israele. È stato assegnato dalle organizzazioni Istituto Milton Friedman, Unione delle Associazioni Italia-Israele, Maccabi World Union, Israel’s Defend & Security Forum (lobby accreditata
0
0
0
RT @FranceskAlbs: The Israeli Army is now targeting starving children in the head and testicles in Gaza, while terrorising others, together….
0
15K
0
RT @MarioBalsaMD: 🚨 New in European Journal of Cancer! TP53 co-mutations in stage I EGFR-mutated LUAD significantly ↑ recurrence risk.https….
0
2
0
Thanks to all the @mcgillu family for support @LFerri123 @sara_najmeh @JonathanCools @ronirayes and @DoctorJSpicer for his guidance and mentorship!.
0
2
7
🚨 Just published!.TP53 co-mutations significantly increase the risk of recurrence in stage I EGFR-mutated LUAD. 🔬 Worse RFS, similar OS → supports the need for treatment escalation even in early-stage disease.
2
16
51
RT @DoctorJSpicer: It seems we are in a bit of a data quagmire. I often get asked how to choose between neoadjuvant versus perioperative im….
0
21
0
RT @danielaranieri: Spero che la forza morale, la dignità e l’intelligenza etica di questo ragazzino tolgano il sonno a coloro che gli hann….
0
73
0
RT @DoctorJSpicer: On the subject of identifying patients for novel neoadjuvant trials, I am so very proud of @MeghanDeMeo, PhD student in….
0
5
0
RT @IREISGufficiale: 🎙️ Tumore al polmone e immunoterapia.Paola Nisticò (IRE) @NisticoLab a @RRCapitale : “Investire in tecnologia e lavora….
0
3
0
RT @StephenVLiu: Navigational bronchoscopy as the new standard for biopsy of lung nodules? Non-inferiority trial @NEJM compared robotic bro….
nejm.org
Each year, millions of pulmonary nodules are identified incidentally or through lung cancer screening, and many involve biopsy to distinguish cancer from benign processes. Both navigational broncho...
0
21
0
RT @NisticoLab: Precision medicine for lung cancer 🫁: a new case report from our institute @IREISGufficiale highlights B cells as crucial p….
0
3
0
🚨 Just published in @jitcancer: our report on spatial transcriptomics of a resectable NSCLC after neoadjuvant chemo-io. A great multidisciplinary effort by @NisticoLab and @IREISGufficiale! Looking forward to many collaborations in this field.
jitc.bmj.com
Neoadjuvant chemo-immunotherapy has significantly improved the treatment landscape for patients with ALK/EGFR wt resectable non-small cell lung cancer (NSCLC), offering novel opportunities for...
3
5
30
RT @DrJNaidoo: Thanks @FedericoCappuz1 #LorenzaLandi #TinaCascone for the invitation to speak at #RomeLung25 on early stage oncogene+ NSCLC….
0
7
0
RT @pompili_cecilia: Terrific afternoon sessions at #RomeLung25 . - Defining and delivering integrated therapies for stage III requires col….
0
8
0
RT @DiFedericoMD: A pleasure to reunite in Bologna with some friends in the thoracic oncology field to discuss the future of resectable lun….
0
2
0